Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced today its fifth patent awarded this year from the U.S. Patent and Trademark Office (USPTO) related to Mg OSTEOCRETE, a portfolio of patents that includes current and future configurations, as well as novel delivery systems.

These five patents further expand Bone Solutions’ industry footprint and allow surgeons and patients to further benefit from the advantages of the Bone Solutions proprietary magnesium-based technology. Mg OSTEOCRETE and Mg OSTEOINJECT (an injectable version of the product) are fast-setting bone substitutes that remodel into bone over time through creeping substitution, meaning they provide needed support to the defect or void during the healing process while transforming into bone at an optimal rate.

“We are pleased to announce the addition of five new patents supplementing our various technologies, ensuring our continued growth and profitability for the company’s future,” said Drew Diaz, CEO of Bone Solutions. “By leveraging our existing technology, Bone Solutions is furthering its mission to improve patient outcomes through our superior magnesium-based orthopedic solutions."

The magnesium component of Mg OSTEOCRETE is the significant differentiator from other bone substitutes on the market. The crystallization reaction from magnesium oxide and the blend of phosphate-based materials allows for ideal osteoconductivity of the product. As a result, Mg OSTEOCRETE and Mg OSTEOINJECT set and cure in situ without migration. The material stimulates cell adhesion, proliferation, and formation of the bone extracellular matrix by osteoblast cells, thus promoting bone growth.

In addition to the superior biological performance of the material, the handling characteristics and formulation are ideal for clinical use. Ready for use after only 30 seconds of mixing, the material is moldable or injectable and is cohesive and adhesive to the area it fills. Once implanted, the material sets quickly, is drillable after only two minutes, and is also radiopaque.

Mg OSTEOCRETE and Mg OSTEOINJECT are currently being distributed to facilities and surgical centers nationwide for immediate clinical use.

About Bone Solutions Inc.

Bone Solutions Inc. is a specialized medical device company dedicated to improving clinical outcomes through biologically safe, fully resorbable magnesium-based orthopedic implant solutions, with a focus on addressing complex procedures and cost reduction. The company is developing various new orthopedic technologies within its FDA-cleared magnesium-based platform.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250805831438/en/

"Bone Solutions is furthering its mission to improve patient outcomes."